Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repositioning Immunotherapy in Veterans With Lung Cancer

NCT06275360 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06275360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repositioning Immunotherapy in Veterans With Lung Cancer
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Recruiting
Start date
March 1, 2024
Completion date
March 31, 2030
Enrollment
25 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer